U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 1031 - 1040 of 1136 results

structurally diverse
Status:
Possibly Marketed Outside US
Source:
Canada:URTICA URENS
Source URL:

Class:
STRUCTURALLY DIVERSE

Group 1 Specified Substance
Status:
Other

Class:
G1 SPECIFIED SUBSTANCE

Group 1 Specified Substance
Status:
Other

Class:
G1 SPECIFIED SUBSTANCE

Group 1 Specified Substance
Status:
US Previously Marketed
First approved in 2012

Class:
G1 SPECIFIED SUBSTANCE

Concept
Status:
Investigational
Source:
NCT00879866: Phase 1 Interventional Completed Lung Cancer
(2009)
Source URL:

Class:
CONCEPT

Concept
Status:
Investigational
Source:
NCT00725582: Phase 1 Interventional Completed Asthma
(2008)
Source URL:

Class:
CONCEPT

Concept
Status:
Investigational
Source:
NCT03094169: Phase 1/Phase 2 Interventional Terminated Solid Tumor, Adult
(2017)
Source URL:

Class:
CONCEPT

Concept
Status:
Investigational
Source:
NCT03801915: Phase 2 Interventional Completed Colon Cancer
(2019)
Source URL:

Class:
CONCEPT

Concept
Status:
Investigational
Source:
NCT03118349: Phase 1 Interventional Terminated Pancreatic Carcinoma
(2017)
Source URL:

Class:
CONCEPT

Showing 1031 - 1040 of 1136 results